Cost-effectiveness of human papillomavirus vaccination in Germany.

Damm, Oliver; Horn, Johannes; Mikolajczyk, Rafael T; Kretzschmar, Mirjam E E; Kaufmann, Andreas M; Deleré, Yvonne; Ultsch, Bernhard; Wichmann, Ole; Krämer, Alexander; Greiner, Wolfgang

Name:

Damm et al.pdf

Size:

1002.Kb

Format:

PDF

Description:

Open Access publication

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Authors

Damm, Oliver
Horn, Johannes
Mikolajczyk, Rafael T

Kretzschmar, Mirjam E E
Kaufmann, Andreas M
Deleré, Yvonne
Ultsch, Bernhard
Wichmann, Ole
Krämer, Alexander
Greiner, Wolfgang

Issue Date

2017

Metadata

Show full item record

Abstract

The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.

Citation

Cost-effectiveness of human papillomavirus vaccination in Germany. 2017, 15:18 Cost Eff Resour Alloc

Affiliation

Hemholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.

Type

Article

Language

ISSN

1478-7547

Collections

Publications of the AG (ESME)

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/